Personalized drug trial aims to stop dangerous sugar crashes after stomach removal
NCT ID NCT07580079
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study tests whether the drug Anakinra can prevent severe drops in blood sugar that happen after eating in a 52-year-old man who had his stomach removed and has kidney failure. The patient will receive either Anakinra or a placebo for 6 weeks, and his blood sugar will be tracked continuously. The goal is to see if the drug reduces the frequency and severity of these episodes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLAMMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Kantonsspital Olten
Olten, Canton of Solothurn, 4600, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.